4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.79
+0.51 (4.96%)
At close: Nov 14, 2025, 4:00 PM EST
10.85
+0.06 (0.56%)
After-hours: Nov 14, 2025, 7:20 PM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $616.49 million as of November 14, 2025. Its market cap has increased by 43.44% in one year.
Market Cap
616.49M
Enterprise Value
266.52M
1-Year Change
43.44%
Ranking
Category
Stock Price
$10.79
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $616.49M, an increase of 6.22%. That is a compound annual growth rate of 1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 616.49M | 139.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
| Dec 11, 2020 | 580.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |